Russian scientists predict that there will soon be a drug to treat cancer

Scientists in the Russian Federation are completing a clinical trial of a new drug that can withstand all types of malignant tumors even when the cancer is in its final stages.

This type of preparation called "Heat Shock Protein" new hope for this cancer patient is expected to go into production in 3-4 years.

In Izvestia, the deputy director of the National Institute of Pure Products of the Federal Biochemical Agency, Professor Andrey Simbirtsev, said the drug had been clinically tested in 3-4. last year.

When tested on mice with malignant tumors and sarcoma (sarcoma) , most cases were cured, meaning "thermal shock protein" has the biological activity needed to treat cancer.

Professor Andrey Simbirtsev.

This new formulation promotes "multipurpose" activity with other types of cancer based on a type of molecule that can synthesize all types of cells.

This protein, in addition to protecting cells from damage, can also help cells produce anti-cancer antibodies and thereby enhance antibody reactions.

However, the amount of this protein in the body is minimal, so Russian scientists have to find a special biotechnology to synthesize it. They created a human gene that produces this protein and then cloned it.

The success of the new drug was discovered by Russian scientists thanks to experiments in space, where there is a suitable environment (without the attraction of the Earth) to create a kind of super-pure crystal serving for X-ray analysis.

Russian scientists have stored the ultrapure protein in the microchip and sent it to the Space Station. After 6 months of "traveling" in the microchip will get the ideal crystal type and transfer to analysis in Russia and Japan.

According to the announcement, the new drug has no side effects, no toxicity.

Professor Andrey Simbirtsev said after a year after the end of the pre-clinical trial, there will be a public announcement of the safety of this new product.